36th Annual JPM Healthcare Conference

Post author:gtmrick
Post published:December 25, 2017
Post category:Uncategorized

In 2018 Vasomune Therapeutics will be at the 36TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

You Might Also Like

Vasomune Therapeutics Appoints Meenu Chhabra to its Board of Directors

Vasomune Receives a US $2.8 Million PRMRP Grant from the US Department of Defense to Develop AV-001 for the Treatment of ALI/ARDS of Any Cause, Including COVID-19

Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference

About

Vasomune Therapeutics 2020 © All Rights Reserved.